🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
16.48
-0.74 (-4.30%)
At close: Nov 20, 2026, 4:00 PM EST
16.50
+0.02 (0.12%)
After-hours: Nov 20, 2026, 7:31 PM EST

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
North America Revenue
403.00M377.00M340.46M
Latin America Revenue
171.00M170.00M130.71M
Europe Revenue
133.00M108.00M80.12M
Asia-Pacific Revenue
23.00M18.00M8.93M
Revenue (Other)
---230.00K
Revenue (Total)
730.00M673.00M560.00M

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Crysvita Revenue
181.00M177.00M134.71M
Dojolvi Revenue
107.00M96.00M88.19M
Evkeeza Revenue
80.00M59.00M32.16M
Mepsevii Revenue
40.00M37.00M30.35M
Total Product Revenue
408.00M369.00M285.42M
Crysvita Royalty Revenue
322.00M304.00M274.82M
Revenue (Other)
---230.00K
Revenue (Total)
730.00M673.00M560.00M